Article
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Season 1, Episode 4: Climbing Your Internal Everest with Samuel Blackman
Summary
In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Samuel Blackman, the co-founder and head of R&D at Day One Biopharmaceuticals. Sam shares his experience trekking to Mount Everest Base Camp and the leadership insights he gained from the journey. The conversation covers topics such as vulnerability, facing fears, asking for help, and overcoming obstacles. Sam emphasizes the importance of authenticity and storytelling in leadership and offers recommendations for those seeking personal and professional growth. Overall, the episode provides valuable lessons and inspiration for leaders in the pharmaceutical industry.
In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Samuel Blackman, the co-founder and head of R&D at Day One Biopharmaceuticals. Sam shares his experience trekking to Mount Everest Base Camp and the leadership insights he gained from the journey. The conversation covers topics such as vulnerability, facing fears, asking for help, and overcoming obstacles. Sam emphasizes the importance of authenticity and storytelling in leadership and offers recommendations for those seeking personal and professional growth. Overall, the episode provides valuable lessons and inspiration for leaders in the pharmaceutical industry.
Takeaways:
-Authenticity and vulnerability are essential in leadership, allowing for deeper connections and support among team members.
-Facing fears and asking for help are signs of strength, not weakness, and can lead to personal and professional growth.
-Overcoming obstacles requires examining the situation, identifying what is holding you back, and finding creative solutions.
-Storytelling is a powerful tool in leadership, enabling effective communication and creating emotional connections.
Related Topics
You May Also Like
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Thakur, Sayanta & Lahiry, Sandeep
Accelerated drug approvals in oncology: Pros and cons
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Laleh Amiri-Kordestani & Richard Pazdur
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
Article
Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD